Mohammad, Jumraida B.

HRN: 07 32 63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CEFTRIAXONE 1G (VIAL)
10/20/2023
10/26/2023
IV
2gm
OD
Intraabdominal Infection
Waiting Final Action 
10/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/21/2023
10/29/2023
IV
750mg
Q8
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: